For example, we recently demonstrated that silent IBD patients were more likely to be homozygous for a polymorphism associated with a voltage-gated sodium channel (NaV1.8) gene (SCN10A).230 Targeted study of novel mechanisms such as these could provide insights leading to more effective and safer analgesic options in the future. The gene discussed is SCN10A; the disease is inflammatory bowel disease.